Status:
COMPLETED
Effects of Intra-articular Stromal Vascular Fraction Injection on Clinical Symptoms and Cartilage Health in Osteoarthritic Knees
Lead Sponsor:
Shu-Hao Chang, MD
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Background: Osteoarthritis (OA) is a prevalent form of arthritis worldwide. Intra-articular stromal vascular fraction (SVF) injections are a potential therapeutic option for patients with OA. This stu...
Eligibility Criteria
Inclusion
- Aged ≥ 35 years.
- Patients with degenerative knee OA confirmed via X-ray and classified according to the Kellgren Lawrence Grading Scale 2\~4.
- Persistent knee pain after nonsurgical treatment.
Exclusion
- Arthritis caused by other systemic or local immune diseases.
- Patients who have undergone total knee replacement surgery.
- Patients who have been administered platelet-rich plasma or hyaluronic acid injections within the past three months.
- Patients with symptoms related to degenerative arthritis in the ankle, which affected the assessment of pain.
- Patients with severe heart problems and coagulation disorders.
- Patients who have taken glucosamine within the previous month.
- MRI exclusion conditions, including patients with a heart rhythm regulator who have received vascular surgery with a hemostatic clip and artificial heart valves.
Key Trial Info
Start Date :
December 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06562101
Start Date
December 4 2020
End Date
June 30 2022
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fu Jen Catholic University Hospital
New Taipei City, Taiwan, 24352